Health
EMA releases guidance for COVID variant vaccine development – Regulatory Focus
The guidance does not foresee the need for large-scale clinical trials to examine safety and efficacy, but rather calls for smaller immunogenicity studies to look…
Posted 25 February 2021 | By Kari Oakes
The European Medicines Agency (EMA) has published a reflection paper laying out what data are needed to support approval of vaccines that protect against variants of SARS-CoV-2, the virus that causes COVID-19.“[I]t is an urgent public health priority to define an expedited regulatory process for the adaptation of vaccines to protect against current or future variants,” wrote the agency in announcing the new guidance. The document comes less than 2 weeks after…
-
Noosa News21 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News13 hours agoRainbow Beach surfer’s untold 7/7 story
-
General20 hours agoParis opens River Seine for public swimming for first time since 1923
-
General4 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89